Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Antibiotic duration for common bacterial infections-a systematic review.

Mo Y. et al, (2025), JAC Antimicrob Resist, 7

Informed consent and risk communication challenges in antimicrobial clinical trials: a scoping review.

Shou Y. et al, (2024), BMJ Open, 14

Concerning the use of aminoglycosides in ventilator-associated pneumonia - Authors' reply.

Chhabra S. and Mo Y., (2024), Lancet Respir Med, 12

Individualised, short-course antibiotic treatment versus usual long-course treatment for ventilator-associated pneumonia (REGARD-VAP): a multicentre, individually randomised, open-label, non-inferiority trial.

Mo Y. et al, (2024), Lancet Respir Med, 12, 399 - 408

Win ratio analyses of piperacillin-tazobactam versus meropenem for ceftriaxone non-susceptible Escherichia coli or Klebsiella pneumoniae bloodstream infections: Post-hoc insights from the MERINO trial.

Hardy M. et al, (2024), Clin Infect Dis

Study protocol: infectious diseases consortium (I3D) for study on integrated and innovative approaches for management of respiratory infections: respiratory infections research and outcome study (RESPIRO).

Ng DHL. et al, (2024), BMC Infect Dis, 24

The burden and dynamics of hospital-acquired SARS-CoV-2 in England.

Cooper BS. et al, (2023), Nature, 623, 132 - 138

Implications of reducing antibiotic treatment duration for antimicrobial resistance in hospital settings: A modelling study and meta-analysis.

Mo Y. et al, (2023), PLoS Med, 20

ACORN (A Clinically-Oriented Antimicrobial Resistance Surveillance Network) II: protocol for case based antimicrobial resistance surveillance

Mo Y. et al, (2023), Wellcome Open Research, 8, 179 - 179

ACORN (A Clinically-Oriented Antimicrobial Resistance Surveillance Network) II: protocol for case based antimicrobial resistance surveillance.

Mo Y. et al, (2023), Wellcome open research, 8

ACORN (A Clinically-Oriented Antimicrobial Resistance Surveillance Network) II: protocol for case based antimicrobial resistance surveillance.

Mo Y. et al, (2023), Wellcome Open Res, 8

Antibiotic Treatment Duration for Bacterial Infections - A Systematic Review and Critical Appraisal

Mo Y. et al, (2022)

Rapid diagnostics for antibiotic resistance: urgent need for strong clinical evidence.

Yin M., (2022), Clin Infect Dis

The potential impact of intensified community hand hygiene interventions on respiratory tract infections: a modelling study.

Pham TM. et al, (2022), Proc Math Phys Eng Sci, 478

Include forthcoming?